[Federal Register Volume 76, Number 202 (Wednesday, October 19, 2011)]
[Notices]
[Pages 64947-64948]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-27022]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Research Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    Notice is hereby given that the Office of Research Integrity (ORI) 
has taken final action in the following case:

[[Page 64948]]

    Marija Manojlovic, University of Pittsburgh: Based on an inquiry 
conducted and written admission obtained by the University of 
Pittsburgh (UP) and additional analysis conducted by ORI in its 
oversight review, ORI found that Ms. Marija Manojlovic, former graduate 
student, Department of Chemistry, UP, engaged in research misconduct in 
research supported by National Institute of General Medical Sciences 
(NIGMS), National Institutes of Health (NIH), grant P50 GM067082, 
National Cancer Institute (NCI), NIH, grant P01 CA078039, National 
Institute of Mental Health (NIMH), NIH, grant U54 MH074411, and 
National Institute of Allergy and Infectious Diseases (NIAID), NIH, 
grant R01 AI033506.
    ORI found that the Respondent engaged in research misconduct by 
falsifying and fabricating the synthesis and spectral data that were 
included in one (1) poster presentation and in one (1) pre-submission 
draft of a paper to be submitted for publication.
    Specifically, ORI found that the Respondent knowingly falsified and 
fabricated the synthesis and characterization, largely in the form of 
manipulated 1H- and 13C-NMR spectral data, for five intermediate steps 
and the final product, 9-desmethylpleurotin, and presented these false 
results in a poster, ``Efforts Towards the Total Synthesis of 
Pleurotin,'' presented at the 2011 National Organic Symposium, and in a 
manuscript, ``Total Synthesis of 9-desmethylpleurotin,'' prepared for 
submission to Angewandte Chemie International Edition.
    Ms. Manojlovic has voluntarily agreed for a period of three (3) 
years, beginning on September 26, 2011:
    (1) To have her U.S. Public Health Service (PHS)-supported research 
supervised; Respondent agreed that prior to the submission of an 
application for PHS support for a research project on which her 
participation is proposed and prior to her participation in any 
capacity on PHS-supported research, she shall ensure that a plan for 
supervision of her duties is submitted to ORI for approval; the 
supervision plan must be designed to ensure the scientific integrity of 
her research contribution; Respondent agreed that she shall not 
participate in any PHS-supported research until such a supervision plan 
is submitted to and approved by ORI; Respondent agreed to maintain 
responsibility for compliance with the agreed upon supervision plan;
    (2) That any institution employing her shall submit, in conjunction 
with each application for PHS funds, or report, manuscript, or abstract 
involving PHS-supported research in which she is involved, a 
certification to ORI that the data provided by Respondent are based on 
actual experiments or are otherwise legitimately derived and that the 
data, procedures, and methodology are accurately reported in the 
application, report, manuscript, or abstract; and
    (3) To exclude herself from serving in any advisory capacity to PHS 
including, but not limited to, service on any PHS advisory committee, 
board, and/or peer review committee, or as a consultant.

FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative 
Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 
750, Rockville, MD 20852, (240) 453-8800.

John Dahlberg,
Director, Division of Investigative Oversight, Office of Research 
Integrity.
[FR Doc. 2011-27022 Filed 10-18-11; 8:45 am]
BILLING CODE 4150-31-P